Facebook
Twitter
Telegram
Report an ErrorEton Pharmaceuticals Financial Statements 2011-2024 | ETON
Annual Financial Statements Eton Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
114 M | 106 M | 93.3 M | 217 M | 122 M | 39.8 M | - | - | - | - | - | - | - |
Shares |
25.6 M | 25.1 M | 25.2 M | 24.3 M | 17.8 M | 6.42 M | - | - | - | - | - | - | - |
Historical Prices |
4.46 | 4.2 | 3.7 | 8.92 | 6.66 | 6.1 | - | - | - | - | - | - | - |
Net Income |
-936 K | -9.02 M | -1.96 M | -28 M | -18.3 M | -12.7 M | - | - | - | - | - | - | - |
Revenue |
31.6 M | 21.3 M | 21.8 M | 39 K | 959 K | - | - | - | - | - | - | - | - |
Cost of Revenue |
10.6 M | 6.93 M | 2.83 M | 436 K | 453 K | - | - | - | - | - | - | - | - |
Gross Profit |
21.1 M | 14.3 M | 19 M | -397 K | 506 K | - | - | - | - | - | - | - | - |
Operating Income |
-1.19 M | -8.26 M | -1.5 M | -27.1 M | -18.6 M | -10.3 M | - | - | - | - | - | - | - |
Interest Expense |
1.06 M | 955 K | 1.04 M | 884 K | 98 K | - | - | - | - | - | - | - | - |
EBITDA |
-291 K | -6.49 M | -1.03 M | -26.8 M | -18.2 M | -10.3 M | - | - | - | - | - | - | - |
Operating Expenses |
22.3 M | 22.6 M | 20.5 M | 26.7 M | 19.1 M | 10.3 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
18.9 M | 18.6 M | 14.3 M | 12.6 M | 7.55 M | 4.69 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Eton Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
25.8 K | 25.7 M | 25.7 M | 25.6 M | 25.5 K | 25.4 M | 25.4 M | 25.1 M | 25.3 M | 24.6 M | 25.3 M | 25.2 K | 24.5 M | 24.3 M | 21.1 M | 21 M | 18.1 M | 17.9 M | 17.9 M | 17.7 K | 17.5 M | 11.6 M | 5.62 M | 4.79 M | 3.55 M | 6 M | 3.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-811 K | - | -579 K | 4.56 M | -2.66 M | - | -3.04 M | -1.56 M | -5.33 M | - | -6.09 M | -2.02 M | 5.12 M | - | -6.5 M | -4.73 M | -9.05 M | -2.7 M | -4.96 M | -3.25 M | -7.41 M | -3.73 M | -2.91 M | -3.08 M | -3.02 M | - | -2.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
7.97 M | - | 7.03 M | 12 M | 5.3 M | - | 3.22 M | 7.36 M | 2.18 M | - | 775 K | 3.07 M | 11.9 M | - | -161 K | 20 K | 99 K | 459 K | 500 K | 500 K | 500 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
2.96 M | - | 2.62 M | 2.32 M | 1.96 M | - | 1.2 M | 2.74 M | 849 K | - | 654 K | 174 K | 1.59 M | - | 144 K | 28 K | 102 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
5.01 M | - | 4.4 M | 9.68 M | 3.35 M | - | 2.02 M | 4.61 M | 1.33 M | - | 121 K | 2.89 M | 10.3 M | - | -17 K | -8 K | -3 K | - | 500 K | 500 K | 500 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-800 K | - | -548 K | 3.88 M | -2.53 M | - | -2.9 M | -1.34 M | -5.09 M | - | -5.85 M | -2.32 M | 5.36 M | - | -6.27 M | -4.54 M | -8.88 M | - | -5.04 M | -3.35 M | -7.55 M | - | -2.37 M | -2.7 M | -2.96 M | - | -2.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
238 K | - | 805 K | - | 265 K | - | 699 K | 466 K | 247 K | - | 766 K | 513 K | 264 K | - | 617 K | 386 K | 195 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-548 K | - | -539 K | 3.89 M | -2.32 M | - | -2.88 M | -1.32 M | -4.91 M | - | -5.82 M | -2.3 M | 5.45 M | - | -5.78 M | -4.21 M | -8.72 M | - | -4.74 M | -3.17 M | -7.5 M | - | -2.33 M | -2.67 M | -2.95 M | - | -2.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
5.81 M | - | 4.95 M | 5.8 M | 5.88 M | - | 4.91 M | 5.95 M | 6.41 M | - | 5.97 M | 5.22 M | 4.94 M | - | 6.26 M | 4.53 M | 8.88 M | 2.66 M | 5.04 M | 3.35 M | 8.05 M | 2.29 M | 2.37 M | 2.7 M | 2.96 M | - | 2.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.16 M | - | 4.34 M | 4.67 M | 5.34 M | - | 4.17 M | 5.26 M | 4.8 M | - | 3.29 M | 3.23 M | 4.06 M | - | 3.43 M | 2.92 M | 2.61 M | - | 1.62 M | 1.91 M | 1.59 M | - | 830 K | 990 K | 1.69 M | - | 1.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency